Technical Analysis for SBBP - Strongbridge Biopharma plc

Grade Last Price % Change Price Change
grade B 5.59 2.95% 0.16
SBBP closed up 2.95 percent on Tuesday, March 19, 2019, on 58 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical SBBP trend table...

Date Alert Name Type % Chg
Mar 19 New Uptrend Bullish 0.00%
Mar 15 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.08%
Mar 15 Outside Day Range Expansion 5.08%
Mar 13 Stochastic Reached Overbought Strength 4.10%
Mar 13 Overbought Stochastic Strength 4.10%
Mar 12 Upper Bollinger Band Walk Strength 4.49%
Mar 12 Upper Bollinger Band Touch Strength 4.49%
Mar 11 Crossed Above 200 DMA Bullish 1.27%
Mar 11 Expansion Breakout Bullish Swing Setup 1.27%
Mar 11 Pocket Pivot Bullish Swing Setup 1.27%

Older signals for SBBP ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Strongbridge Biopharma plc, a biopharmaceutical company, through its subsidiary, Cortendo AB (publ), develops, acquires, and commercializes product candidates that target rare diseases. The company's lead product candidate, COR-003 (levoketoconazole), is a cortisol inhibitor that is in the Phase 3 trial for the treatment of endogenous Cushing's syndrome. It also has two product candidates, COR-004 and COR-005 in Phase 2 clinical development to treat acromegaly. In addition, it is developing BP-2001, a pre-clinical product candidate for the treatment of diabetes. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is based in Trevose, Pennsylvania.
Chemistry Biopharmaceutical Organ Systems Chemical Compounds Diabetes Rare Diseases Chloroarenes Treatment Of Diabetes Acromegaly Cushing's Syndrome Adrenal Gland Disorders Cortisol Endogenous Cushing's Syndrome Piperazines
Is SBBP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.25
52 Week Low 3.82
Average Volume 145,089
200-Day Moving Average 5.1221
50-Day Moving Average 4.925
20-Day Moving Average 5.175
10-Day Moving Average 5.318
Average True Range 0.2295
ADX 26.08
+DI 31.3214
-DI 11.4993
Chandelier Exit (Long, 3 ATRs ) 5.0015
Chandelier Exit (Short, 3 ATRs ) 5.1885
Upper Bollinger Band 5.7146
Lower Bollinger Band 4.6354
Percent B (%b) 0.88
BandWidth 20.854106
MACD Line 0.1722
MACD Signal Line 0.15
MACD Histogram 0.0222
Fundamentals Value
Market Cap 197.52 Million
Num Shares 35.3 Million
EPS -2.93
Price-to-Earnings (P/E) Ratio -1.91
Price-to-Sales 139.82
Price-to-Book 21.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.98
Resistance 3 (R3) 5.97 5.83 5.92
Resistance 2 (R2) 5.83 5.73 5.84 5.89
Resistance 1 (R1) 5.71 5.67 5.77 5.72 5.87
Pivot Point 5.57 5.57 5.60 5.58 5.57
Support 1 (S1) 5.45 5.47 5.51 5.46 5.31
Support 2 (S2) 5.31 5.41 5.32 5.29
Support 3 (S3) 5.19 5.31 5.27
Support 4 (S4) 5.20